Department of Oncology Surgery, Beijing Shijitan Hospital, Capital Medical University, Tieyilu 10 Yangfangdian, Haidian, Beijing, 100038, People's Republic of China.
Department of Oncology Surgery, Ninth School of Clinical Medicine, Peking University, Beijing, China.
Eur J Med Res. 2022 Jul 25;27(1):130. doi: 10.1186/s40001-022-00759-z.
In recent years, with the increasing incidence of colorectal cancer (CRC) and its high fatality rate, CRC has seized the attention of the world. And liver metastasis, as the main cause of death of CRC, has become the leading cause of treatment failure in CRC, especially metachronous liver metastasis, have caused patients who underwent bowel resection to experience multiple tortures.
Metachronous liver metastasis has severely affected the quality of life and prognosis of patients. Therefore, in this review, we discuss risk factors for metachronous liver metastasis of CRC, which is the premise for effective intervention for CRC patients who suffer metachronous liver metastasis after undergoing surgery, as well as the signaling pathways associated with CRC.
The occurrence of metachronous liver metastasis is closely related to histology-based prognostic biomarkers, serum-based biomarkers, tumor microenvironment, pre-metastatic niche, liquid biopsy and tissue-based biomarkers. Further research is required to explore the risk factors associated with liver metastasis of CRC.
近年来,随着结直肠癌(CRC)发病率的不断上升及其死亡率居高不下,CRC 已引起全球关注。而肝转移作为 CRC 的主要致死原因,成为 CRC 治疗失败的首要原因,尤其是异时性肝转移,导致接受肠切除术的患者经历多次折磨。
异时性肝转移严重影响患者的生活质量和预后。因此,在本次综述中,我们讨论了结直肠癌异时性肝转移的危险因素,这是对接受手术后发生异时性肝转移的 CRC 患者进行有效干预的前提,以及与 CRC 相关的信号通路。
异时性肝转移的发生与基于组织学的预后生物标志物、基于血清的生物标志物、肿瘤微环境、转移前生态位、液体活检和组织学生物标志物密切相关。需要进一步研究以探讨与 CRC 肝转移相关的危险因素。